This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

Motorists across the UK are facing a significant surge in private parking fines, with new data revealing a 24 per cent annual increase in tickets issued by private companies. This sharp rise coincides ...

Ayyoun is a staff writer who loves all things gaming and tech. His journey into the realm of gaming began with a PlayStation 1 but he chose PC as his platform of choice. With over 6 years of ...

While the most obvious change to macOS Tahoe 26 is the newly rounded and translucent Liquid Glass interface appearance, there are also a variety of neat new features and customization options that you ...

Kathy Gibson reports – Online retail is set to account for 10% of all retail spend in South Africa within just a few months, reaching a value of R130-billion by the end of this year. Arthur Goldstuck, ...

THE Great British Sewing Bee host Sara Pascoe is leaving the show. She is being replaced after three series - just a year on from taking maternity leave. Bafta-winning actress Sophie Willan, best ...

THE annual “Second-hand September” campaign has begun, with shoppers urged to buy pre-owned clothes and help save the planet. But despite huge demand — and the European market for second-hand products ...

Today 25 Sep, 2025, Lakki Marwat Namaz Timings are Fajr 4:44 AM, Dhuhr 12:08 PM, Asr 4:27 PM, Maghrib 6:09 PM & Isha 7:31 PM. The city azan, salat schedule & 7 days time table is also provided. Daily ...

The ChatGPT maker is eyeing the launch of its own productivity suite with generative AI built in, directly attacking Microsoft’s multibillion dollar Microsoft 365 office suite business. In this ...

2.0m3 Quality European made vertical feed mixer. New stock always on order to meet market demand. FARMTECH Vertical Mixer-Feeders are designed to bring various animal feed into a homogenous mixture ...

Dr Maurie Markman discusses a recent study focused on immunotherapy in the inpatient setting for patients with stage IV cancer.